Skip to content

To STUDY ON THE EFFICACY OF AABHADI CHOORNA WITH VAJIGANDHADI TAILA MATRA BASTI IN THE MANAGEMENT OF GRIDHRASI WITH SPECIAL REFERENCE TO SCIATICA AND ITS COMPARISON WITH THE EFFICACY OF SAHACHARADI KASHAYA WITH VAJIGANDHADI TAILA MATRA BASTI

A RANDOMIZED OPEN-LABEL CLINICAL STUDY ON THE EFFICACY OF AABHADI CHOORNA WITH VAJIGANDHADI TAILA MATRA BASTI IN THE MANAGEMENT OF GRIDHRASI WITH SPECIAL REFERENCE TO SCIATICA AND ITS COMPARISON WITH THE EFFICACY OF SAHACHARADI KASHAYA WITH VAJIGANDHADI TAILA MATRA BASTI - nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105380
Enrollment
30
Registered
2026-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

None listed

Sponsors

Dr Vaishnavi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects between the age group of 31 - 60 years irrespective of gender, religion, occupation and socioeconomic status 2.Subjects fulfilling the diagnostic criteria of Gridhrasi. 3.Subjects who are indicated and fit for Matra Basti Karma. 4.Subjects who are willing to give a written consent for the treatment, will be conveyed in the local language in which the subject can understand are included.

Exclusion criteria

Exclusion criteria: 1.Matra Basti is contraindicated in individuals who follow Divaswapna and present with symptoms like loss of appetite, sour belching, abdominal heaviness, drowsiness, and poor digestion. 2.Uncontrolled Systemic diseases like Hypertension, Diabetes mellitus, cardiac issues and on concurrent medications which interfere with the course of treatment will be excluded. 3.Subjects with diagnosed conditions of spinal deformity, severe traumatic condition like compressive fractures, Quada equina compression, tuberculosis of the spine or any infective and inflammatory diseases of spine , benign or malignant tumors of spine ,Post-surgical conditions of lumbar spine, Avascular Necrosis of head of femur.

Design outcomes

Primary

MeasureTime frame
Change in symptoms of Gridhrasi on the basis of Straight Leg Raise test (SLR test), Oswestry Lowback Disability Index scale (ODI Index). Timepoint: Trial period 30 days Drug free follow up period 15 days Total study duration 45 days

Secondary

MeasureTime frame
Generation of in - depth analysed data on the different aspects of the disease. Generation of data on possible unexpected drug reaction. Improvement in Quality of life. Timepoint: Trial period 30 days Drug free follow up period 15 days Total study duration 45 days

Countries

India

Contacts

Public ContactDr Gopalakrishna G

SRI SRI COLLEGE OF AYURVEDIC SCIENCE AND RESEARCH

lakshmimp1981@gmail.com9448173128

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026